Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group

F. Grosso, L. D’Ambrosio, M. Zucchetti, T. Ibrahim, S. Tamberi, C. Matteo, E. Rulli, D. Comandini, E. Palmerini, G.G. Baldi, A. DeCensi, M. Bergaglio, D. Marra, E. Marchesi, G. Siri, M. D’Incalci, G. Grignani

Research output: Contribution to journalArticlepeer-review

Original languageItalian
Pages (from-to)4726-4734
Number of pages9
Issue number21
Publication statusPublished - 2020

Cite this